Artificial Intelligence Blogs

06|13|25

AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era

At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]

06|10|25

AI, Biomarkers & The Future of Oncology: Expert Insights From ASCO 2025 

At this year’s ASCO Annual Meeting, the future of oncology came into sharper focus — and EVERSANA INTOUCH was at the center of the conversation. From the expanding role of AI to the evolving biomarker landscape, our experts shared insights that are shaping the future of cancer care. 

06|02|25

2025 Pharma Generative Search Report

Generative AI has rapidly reshaped the pharma landscape, embedding itself into nearly every digital tool we use. With platforms like Google’s AI Overviews and ChatGPT redefining search, pharma marketers must rethink how they reach and engage audiences in this evolving ecosystem. Our innovative SEO team conducted a comprehensive analysis within the pharma industry. Download the report to see our findings.

05|07|25

2025 and Beyond: Generative Search Predictions

In 2024 and 2025, the search landscape has seen massive evolutions through the introduction of artificial intelligence (AI) and generative search. EVERSANA INTOUCH’s innovative SEO team has stayed ahead of these changes, proactively embracing and adapting to new paradigms. Learn about the team's predictions for 2025 and beyond in this blog.

04|11|25

EVERSANA Unveils EVERSANA ORCHESTRATE™ MLR to Transform the Medical, Legal & Regulatory Process

CHICAGO – 10 April, 2025 – EVERSANA, a leading provider of commercial services to the life sciences industry, today announced the next milestone in its journey to transform and innovate commercialization with the launch of ​​EVERSANA ORCHESTRATE MLR, an AI-powered, industry-integrated platform that revolutionizes the Medical, Legal, and Regulatory (MLR) process. 

03|20|25

SXSW 2025: A Mandate, A Path, A Tool

At SXSW 2025, we heard loud and clear: Pharma marketers are facing the biggest challenge of our careers. But it's also the most rewarding challenge, and one that has sharpened our superpowers. In this POV, we discuss how we can harness these opportunities to navigate the challenges ahead.

03|13|25

AI With A Human Touch: Ensuring Authenticity in AI Marketing

In this POV, Morgan Hartzell, VP, Client Services, explores several key strategies to ensure marketing remains genuine and trustworthy, while still leveraging the benefits of AI technology.

01|30|25

The Power of Data and Machine Learning to Optimize HCP Prescription Volume

In a recently published article from Med Ad News, co-authors Iyiola Obayomi, SVP, Managing Director, Data & Analytics, at EVERSANA INTOUCH, and Pierantonio Russo, MD, FCPP, FAAP, STS, Chief Medical Officer at EVERSANA, discuss the power of data and analytics and machine learning (ML) to optimize HCP targeting and prescription volume.

01|28|25

Pharma Marketing in 2025: Talking Trends With Angela Tenuta

In a rapidly evolving industry, staying ahead of the curve is critical. In PM360's article, “What Is Pharma Marketing in 2025?” Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. Read the blog to learn more.

12|02|24

What AI Means for DTC Marketing

In the rapidly evolving landscape of direct-to-consumer (DTC) marketing, artificial intelligence (AI) is emerging as a transformative force. For large pharmaceutical companies and their senior brand marketers, understanding and leveraging AI can significantly enhance the effectiveness and efficiency of their marketing strategies. Here’s how AI is reshaping DTC marketing and what it means for the industry.